Pacer Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,038	Closed	-$56.1K	–	2569
2024 Q2	$56.1K	Buy	1,038 +500	+93%	+$27K	﹤0.01%	3056
2024 Q1	$36.7K	Buy	+538	New	+$36.7K	﹤0.01%	3297